PerkinElmer Unveils New Analytical Solutions at Pittcon 2006 to Drive Innovation, Precision and Reliability.

ORLANDO, Fla. -- Showcases "Smart Thinking" to Help Customers Overcome Complex Challenges

PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced new application-based laboratory solutions and product enhancements for the environmental, pharmaceutical, materials and academic research market segments at PITTCON(R) 2006, March 13-15, booth # 2669.

New, innovative solutions being showcased include five turnkey Ozone Precursor Analyzer systems for remote environmental air monitoring. Combining the Clarus(R) 500 multidimensional Gas Chromatograph (GC) with PerkinElmer's recently introduced family of TurboMatrix(TM) Thermal Desorbers, the new systems offer single-tube or automated (50-tube) configurations with either manual or fully integrated programmable pneumatic control (PPC) for maximum ease-of-use and reliability for ozone precursor and air toxics analyses.

PerkinElmer is also featuring its latest WinLab32(TM) for Atomic Absorption (AA) software with an integrated Quality Control (QC) Charting option to provide customers with a convenient and comprehensive solution for increasing flexibility and productivity. The QC Charting feature allows laboratories to quickly and easily prepare quality control charts from results, as well as store customized templates for future use, without purchasing additional, third-party software.

"Solving complex analytical problems in today's demanding laboratory environments requires innovation, precision and reliability," said Robert F. Friel, president of PerkinElmer Life and Analytical Sciences. "Our new product introductions and enhancements at PITTCON 2006 will help provide customers with 'smart thinking' solutions to create greater efficiency and accuracy in their laboratories."

Additional product introductions include Jade(TM) DSC. A new member of the Company's Thermal Analysis line of heat-flux Differential Scanning Calorimeters, Jade DSC offers new features to expand application capabilities and operating convenience for routine applications, QA/QC and education, including: a liquid nitrogen cooling system to automate low temperature testing; improved baseline flatness and stability to assure accurate measurements; and advances in autosampler control to increase sample throughput and improve productivity.

LABWORKS(TM) LIMS v5.9 will also be unveiled at the show. The latest version of PerkinElmer's LABWORKS laboratory information management system is the first release built on an entirely new computing platform. The new architecture takes LABWORKS' long tradition of highly-configurable systems to a new level of tailoring. Using a new implementation tool kit, users can customize site-specific data structure and presentation of their LIMS. Version 5.9 also includes expanded security features for greater regulatory compliance with ISO 17025 and other standards.

Other products and services that will be showcased at PerkinElmer's booth at PITTCON include:

--TurboMatrix(TM) 650 ATD - Incorporating PPC, this thermal desorber provides outstanding analytical performance in an automated sample-tube handling system for unattended analysis of up to 50 samples for monitoring volatile organic compounds, occupational health and safety, and environmental protection.

--TurboMass(TM) 5.2 GC/MS Software - Assures method compliance and increased productivity in the environmental laboratory with expanded resources for evaluation and reporting Clarus(R) 500 GC/MS information, including a custom compound list capability that allows operators to run a full batch of samples and select which compounds are to be reported to each individual client.

--The integrated Series 200 HPLC PDA System with IRIS(TM) Spectral Processing Software - Improves data quality and enhances laboratory workflow through its full suite of functionality and an intuitive user interface protected under a fully 21 CFR Part 11-compliant architecture. IRIS provides dedicated views for peak purity, spectral comparison, library search, signal extraction, and up to 10 chromatographic signals automatically extracted. Additionally, the IRIS software offers multi-level user permissions, password-protected access control, full audit trailing, as well as configurable e-signature points.

--PerkinElmer's Spectrum(TM) 100 FT-IR and 100N FT-NIR Spectrometers - The gold standard in FT-IR spectrometer performance enables laboratories to achieve the highest spectral quality and most reproducible results with ease and efficiency. The series encompasses a broad array of features and advantages, including a new and improved Universal Attenuated Total Reflectance (UATR) accessory, new fiber optic near infrared (NIR) probe, Go Button, and an enhanced version of PerkinElmer's Spectrum and AssureID(TM) software packages. This software provides a laboratory workflow-driven approach to testing materials for an easy-to-use measurement system that integrates seamlessly into operations in laboratories of any size.

--PerkinElmer LAMBDA(TM) 950, 850 and 650 UV/Vis/NIR and UV/Vis Spectrophotometers - The industry standard for high performance, flexibility and convenience, each model includes the same unparalleled range of modular components and snap-in accessories to tackle the widest range of applications in the industry. The LAMBDA(TM) series includes the PerkinElmer Universal Reflectance Accessory (URA) - a breakthrough sampling accessory for absolute reflectance measurements at variable angles that automates angle changes, eliminates alignment issues, and permits instant switching between reference and sample.

--PerkinElmer Spectrum(TM) Spotlight(TM) 300 FT-IR Imaging System - Enables rapid extraction and analysis of data on molecular composition from a wide range of materials, from pharmaceutical tablets, to diseased human tissues, to forensic evidence, to the most complex chemical materials. The system's speed, unmatched spatial resolution, spectral range and superior signal to noise ratio enable the Spotlight to deliver the highest quality chemical imaging data in the market.

--AAnalyst(TM) 200 Touch-Screen-Software - The enhanced software includes sample identification and dilution factors, as well as improved control of the AS-93plus autosampler to help increase flexibility and ease-of-use. In addition, the expansion of the software's multiple-language capability includes three new languages - Greek, Portuguese and Polish - to help provide users with even more options to select their language of choice.

--The JANUS(TM) Automated Workstation - With proprietary Modular Dispense Technology(TM) (MDT), the workstation delivers real-time and future adaptability in throughput, capacity and dynamic volume range without compromise in performance or methodology. JANUS provides a comprehensive, scalable platform with extended adaptability and functionality to meet customers' needs for complete assay automation.

--OneSource(R) Professional Services - Provides the skills and capabilities to make laboratories more productive and efficient. Services include: project management; technical support; multi-vendor validation; multi-vendor maintenance; multi-vendor repair; asset management; eLearning programs; and local and international equipment and total lab moves.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries; (2) risks related to our failure to introduce new products in a timely manner; (3) our ability to comply with financial covenants contained in our credit agreements and our debt instruments; (4) a delay in resolution of the Company's tax audits and an adverse determination with respect to the Company's tax audits by the Internal Revenue Service or other taxing authorities; (5) cyclical downturns continuing to affect several of the industries into which we sell our products; (6) our ability to adjust our operations to address unexpected changes; (7) our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business; (8) the loss of any of our licenses that may require us to stop selling products or lose competitive advantage; (9) competition; (10) regulatory compliance; (11) regulatory changes; (12) our failure to obtain and enforce intellectual property protection; (13) our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets; (14) other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Other Information

Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging. Photonics markets include sensors and specialty lighting.

PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.5 billion in 2005, has 8,000 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.